In older adults living in residential aged care facilities with unresolved agitation, can essential oils when compared to placebo reduce their agitation?

School of Nursing and Midwifery, University of Western Sydney0 sites60 target enrollmentFebruary 4, 2014

Overview

No summary available.

Registry

who.int

Start Date

February 4, 2014

End Date

TBD

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

School of Nursing and Midwifery, University of Western Sydney

•Older adult participant inclusion criteria
•\*Participants are aged 65 years or older.
•\*Participants must be living full time in a residential aged care facility (RACF) and have been a resident for 3 months to ensure they are familiar with the RACF processes and settled into their environment.
•\*A cognitive level of moderate or higher as demonstrated by a score above 10 on the mini mental state examination \[MMSE] (American Psychiatric Association 1991\).
•\*Recorded agitated behaviours on at least one of the Aged Care Funding Instrument \[ACFI] behaviours domain questions. Behaviour question being question 7 wandering, question 8 verbal behaviours and question 9 physical agitations.
•\*Be stable upon medication for 3 months as confirmed by medication charts. Any changes in psychotropic medications needs to be reported to investigator.
•\*At least one, agitated behaviour with a frequency of at least 6 occurrences observed by the nurse in the last two weeks assessed on the NPI at baseline.
•\*Have no allergy to Lavender, Lemon Balm or Sunflower oil to be assessed at baseline.
•\*Ability to detect scent as demonstrated in a scent test at baseline.
•\*The participant or the person responsible, have given consent.

•Older adult participant exclusion criteria
•\*Diagnosis of psychosis or agitation resulting from brain damage.
•\*The presence of an acute life\-threatening condition as reported by staff or the local medical officer.
•\*Any condition that is likely to confound the study such as schizophrenia or Parkinson disease or another medical condition as determined by investigator to interfere with interpretation of study results.